coronaviru
mhvjhm
infect
rat
provid
use
model
studi
pathogenesi
virusinduc
central
nervou
system
diseas
analyz
role
immun
respons
defin
mhvjhm
antigen
test
protect
efficaci
vaccinia
viru
vv
recombin
express
either
nucleocapsid
n
spike
protein
strong
protect
mediat
anim
immun
recombin
vv
encod
wildtyp
protein
vvswildtyp
wherea
vv
recombin
express
mutant
protein
protect
effect
recombin
vv
encod
n
protein
vvn
induc
humor
tcell
respons
prevent
acut
diseas
regardless
immun
protocol
experi
challeng
otherwis
lethal
dose
mhvjhm
perform
prior
induct
virusneutr
antibodi
studi
monoclon
antibodi
mrc
show
elimin
subset
tcell
abrog
protect
effect
result
indic
tcell
prime
recombin
vv
express
wildtyp
protein
primari
mechan
immunolog
defens
mhvjhm
infect
rat
coronaviru
infect
central
nervou
system
cn
interest
model
analyz
mechan
inflammatori
demyelin
viru
persist
particular
murin
coronaviru
strain
mhvjhm
induc
differ
cours
encephalomyel
mice
rat
l
lewi
rat
differ
form
diseas
observ
acut
encephalomyel
ae
rapidli
progress
diseas
lead
death
anim
subacut
demyelin
encephalomyel
sde
paralyt
diseas
character
select
loss
myelin
inflamm
white
matter
cn
host
immun
respons
mhvjhm
play
critic
role
protect
acut
diseas
also
modul
develop
chronic
diseas
associ
demyelin
cellular
cellmedi
humor
b
cellmedi
respons
involv
although
role
differ
compon
immun
system
regard
defin
viru
protein
cours
infect
clear
evid
passiv
transfer
antibodi
specif
spike
protein
viru
provid
protect
lethal
infect
moreov
antivir
antibodi
alter
phenotyp
diseas
mice
rat
also
protect
neutral
antibodi
induc
immun
mice
purifi
protein
protein
decapeptid
result
impli
humor
immun
respons
may
suffici
observ
protect
mhvjhm
infect
atcellmedi
immun
also
believ
crucial
control
coronaviru
infect
adopt
transfer
experi
cell
protect
mhvjhm
infect
demonstr
experi
report
use
recombin
vaccinia
virus
vv
express
specif
mhv
protein
determin
abil
differ
viral
antigen
induc
antivir
immun
earli
immun
furthermor
deplet
tcell
subset
vivo
analyz
role
cell
protect
immun
respons
infect
rat
use
vv
recombin
cdna
copi
mhvjhm
nucleocapsid
n
protein
gene
protein
gene
clone
smai
site
transfer
vector
pscll
kindli
provid
b
moss
nation
institut
health
bethesda
md
two
differ
gene
cdna
use
first
wildtyp
gene
cdna
differ
gene
sequenc
publish
schmidt
et
al
posit
g
c
c
g
g
c
totth
protein
express
gene
fusogen
second
variant
gene
cdna
differ
publish
sequenc
posit
g
c
c
g
c
gthe
protein
express
gene
fusogen
unpublish
observ
plasmid
use
introduc
mhvjhm
gene
thymidin
kinas
tk
gene
wildtyp
vv
vvwt
homolog
recombin
recombin
refer
asvvn
vvswildtyp
v
v
sc
r
express
n
nonfusogen
variant
protein
respect
express
mhvjhm
protein
vvn
vvswddtype
test
immunofluoresc
indirect
immunofluoresc
cultur
dbtcell
infect
vvwt
vvswiidtyp
multipl
infect
lo
cell
fix
buffer
formaldehyd
incub
monoclon
antibodi
mhvjhmn
protein
follow
incub
fluorescein
isothiocyanateconjug
goat
antimous
igg
dako
copenhagen
denmark
specifi
pathogenfre
lewi
rat
purchas
zentralinstitut
fur
versuchstierzucht
hannov
frg
lewi
rat
week
old
inocul
either
singl
shot
immun
three
four
time
multipl
shot
immun
interv
intraperiton
ip
injectionsof
x
x
pfu
vvrecombin
seven
day
singl
shot
immun
day
last
vv
inocul
anim
challeng
intracerebr
ic
inocul
mhvjhm
volum
yl
left
brain
hemispher
purpos
use
mhvjhm
wildtyp
viru
passag
three
time
mous
brain
twice
rat
brain
viru
design
anim
observ
appear
clinic
sign
encephalomyel
lewi
rat
dissect
histolog
examin
brain
variou
interv
postinfect
pi
antivir
igg
serum
infect
anim
measur
elisa
micropl
coat
purifi
viru
ag
describ
previous
ratio
calcul
rel
graph
obtain
standard
antiserum
mhvjhm
immun
rat
protein
specif
antivir
antibodi
test
immunostain
western
blot
ag
use
purifi
mhvjhm
viru
separ
pagesd
electroblot
onto
nitrocellulos
membran
virusneutr
antibodi
measur
plaqu
number
reduct
assay
dbtcell
antibodi
titer
result
reduct
plaqu
number
calcul
describ
previous
lo
detect
infecti
viru
homogen
cn
tissu
dbt
cell
cultur
inocul
virussuspens
cluster
platesth
number
plaqu
count
determin
amount
viru
present
brain
lewi
rat
vaccin
withvvrecombin
deplet
ip
inocul
mab
mrc
concentr
mg
iggml
one
dose
given
day
infect
follow
second
dose
day
prior
mhvjhm
infectionth
effici
deplet
monitor
facscan
analysi
hewlettpackard
control
rat
day
postmhvjhm
challeng
superfici
cervic
lymph
node
prepar
singlecel
suspens
stain
antibodi
tissu
cultur
supernat
specif
isotyp
control
antibodi
human
inactiv
rat
tcell
surfac
molecul
express
mhvjhm
n
swildtyp
protein
confirm
indirect
immunofluoresc
use
mab
mhvjhm
n
protein
respect
fig
diffus
membran
stain
extens
syncytia
format
caus
fusogen
activ
recombin
protein
seen
vvswildtypeinfect
dbt
cell
contrast
n
protein
local
cytoplasm
vvnor
dbt
cell
potenti
recombin
vv
induc
antibodi
specif
mhvjhm
structur
protein
determin
vaccin
lewi
rat
pool
serum
sampl
test
elisa
antivir
igg
viru
neutral
activ
monitor
protein
specif
demonstr
immunostain
western
blot
purifi
mhvjhm
viru
ag
fusogen
vvswildtyp
recombin
induc
humor
immun
respons
singl
shot
immun
tabl
high
level
sspecif
antibodi
virusneutr
activ
present
day
immun
contrast
vv
recombin
express
nonfusogen
protein
induc
specif
humor
immun
respons
whether
singl
shot
multipl
shot
vaccin
vvn
recombin
elicit
low
level
nucleocapsidspecif
antibodi
four
immun
neutral
assay
antibodi
virusneutr
activ
evalu
protect
effect
individu
coronaviru
protein
mhvjhminduc
encephalomyel
adult
lewi
rat
vaccin
intraperiton
recombi
lewi
rat
immun
vv
recombin
challeng
x
x
mhvjhm
day
later
multipl
shot
immun
rat
immun
four
time
interv
vv
recombin
four
day
last
vv
immun
anim
infect
mhvjhm
nant
vv
vvwt
day
prior
intracerebr
ic
infect
lethal
dose
mhvjhm
uninfect
vvwt
vaccin
anim
lewi
rat
immun
vvn
develop
acut
encephalomyel
within
day
mhvjhm
challeng
die
contrast
anim
vaccin
vvswildtyp
overcam
acut
phase
even
higher
challeng
dose
appli
tabl
attempt
increas
protect
effect
vvn
immun
rat
inject
four
time
respect
vv
recombin
challeng
ic
day
last
vv
inocul
lethal
dose
mhvjhm
protect
effect
observ
rat
immun
either
vvwt
v
v
sc
r
vvn
invari
develop
acut
lethal
encephalomyel
viru
reisol
perform
variou
time
point
pi
cultiv
homogen
brain
tissu
dbtcell
day
p
brain
tissu
rat
contain
x
pfu
mhvjhm
prior
vaccin
vvwt
contrast
anim
immun
vvswildtyp
infecti
viru
detect
day
ic
challeng
day
pi
brain
tissu
one
five
lewi
rat
yield
singl
mhvjhm
viru
plaqu
observ
indic
clearanc
infecti
mhvjhm
cn
occur
fast
rat
prime
vvswildtyp
immun
antivir
neutral
antibodi
respons
serum
sampl
rat
immun
vvswfidtyp
analyz
plaqu
number
reduct
assay
elisa
test
control
rat
vaccin
vvwt
challeng
mhvjhm
develop
measur
procedur
see
tabl
deplet
tcell
start
day
day
prior
mhvjhm
infect
humor
immun
respons
mhvjhm
die
day
infect
antivir
antibodi
respons
vvswilpeimmuni
rat
significantli
enhanc
follow
mhvjhm
challeng
compar
sera
unchalleng
rat
time
point
agreement
find
mhvjhm
challeng
result
also
earlier
rais
increas
amount
virusneutr
antibodi
howev
infecti
viru
alreadi
elimin
brain
tissu
detect
amount
neutral
antibodi
measur
activ
cell
import
restrict
spread
mhvjhm
viru
deplet
abrog
protect
immun
respons
deplet
cell
repertoir
treatment
vvswildtyp
immun
rat
mab
effici
deplet
monitor
fac
analysi
cervic
lymph
node
cell
obtain
control
rat
day
challeng
mhvjhm
deplet
protocol
result
physic
loss
tcell
absenc
cell
vvswildtyp
immun
rat
surviv
intracerebr
challeng
lethal
dose
mhvjhm
tabl
despit
immun
vvswildtyp
rat
develop
acut
encephalomyel
die
within
time
control
rat
challeng
x
mhvjhm
analyz
contribut
differ
viru
protein
cellular
humor
immun
cours
coronaviru
infect
immun
lewi
rat
select
vv
recombin
establish
antivir
immun
challeng
vaccin
rat
mhvjhm
time
point
virusneutr
igg
antibodi
detect
result
indic
presenc
cell
indispens
requir
overcom
infect
mhvjhm
cellular
immun
respons
primarili
respons
protect
viru
elimin
acut
phase
diseas
process
furthermor
detect
patholog
chang
histolog
analysi
brain
tissu
rat
dissect
variou
time
point
mhvjhm
challeng
data
shown
assum
therefor
neutral
antibodi
essenti
factor
mediat
protect
acut
stage
diseas
conclus
also
support
observ
antibodi
produc
within
cn
mhvjhminfect
rat
prevent
onset
acut
viral
encephalomyel
mice
ctl
predomin
effector
cell
elimin
infect
cell
find
whether
activ
proteinspecif
cell
capabl
restrict
viru
spread
cell
elimin
vv
swidtypeimmun
rat
treatment
monoclon
antibodi
similar
vvwtimmun
control
rat
anim
deplet
die
within
day
mhvjhm
challeng
experi
employ
less
effici
deplet
cell
observ
vvswildtypeimmun
rat
remain
protect
low
percentag
tcell
detect
data
shown
result
indic
rat
system
mhvjhm
proteinspecif
lymphocyt
contribut
protect
viru
clearanc
pronounc
protect
immun
induc
vaccin
fusogen
vv
recombin
surprisingli
vaccin
v
v
sc
r
could
induc
protect
immun
regardless
vaccin
protocol
preliminari
experi
indic
within
cell
compart
variant
protein
process
beyond
precursor
stage
data
shown
assum
therefor
antigen
process
protein
result
immun
respons
relev
protect
number
virushost
system
immun
respons
nucleocapsid
protein
alon
mediat
protect
result
vari
extent
differ
system
immun
schedul
consid
exampl
immun
purifi
influenza
nucleoprotein
np
induc
protect
wherea
vaccin
vvrecombin
express
np
induc
protect
immun
experi
nucleocapsidspecif
humor
cell
respons
induc
vvn
low
delay
death
notic
vvn
vaccin
rat
compar
control
anim
data
shown
nevertheless
vaccin
vvn
recombin
prevent
acut
diseas
regardless
immun
protocol
howev
assum
nspecif
cell
respons
import
function
promot
cellular
immun
respons
sinc
recent
data
demonstr
n
protein
domin
tcell
antigen
rat
mice
protect
mediat
vvswildtyp
depend
presenc
sspecif
cell
without
essenti
particip
antibodi
indirect
measur
specif
cell
respons
establish
tcell
line
vv
recombin
immun
rat
measur
specif
prolifer
assay
although
sspecif
tcell
demonstr
lymphoid
organ
rat
diseas
sde
respons
observ
follow
immun
vvswildtyp
v
v
sc
r
contrast
vvn
elicit
specif
tcell
respons
furthermor
biolog
potenti
activ
mhvjhm
proteinspecif
cell
mediat
protect
reveal
transfer
experi
therefor
unprim
rat
effici
viru
elimin
surviv
acut
diseas
stage
requir
cell
interact
wherebi
rel
impact
subset
may
strongli
depend
epitop
specif
mhv
protein
